MeSH D018410 - bacterial pneumonia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D018410:Â
Bacterial pneumonia
D011019:Mycoplasma pneumonia
D011022:Rickettsial pneumonia
0 Companies
0 Drugs
Success rate
D011023:Staphylococcal pneumonia
0 Companies
0 Drugs
Success rate
D045729:Mycoplasmal pneumonia of swine
0 Companies
0 Drugs
Success rate
D048089:Enzootic pneumonia of calves
0 Companies
0 Drugs
Success rate
D061387:Chlamydial pneumonia
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Tigecycline | Tigecycline |  | 2018-01-18 |  |  |
| Tigecycline | Tigecycline Accord |  | 2020-04-17 |  |  | |
| Alembic Pharmaceuticals | Linezolid | Linezolid |  | 2015-12-21 |  |  |
| Moxifloxacin | Moxifloxacin |  | 2019-02-13 |  |  | |
| Alkem Laboratories | Linezolid | Linezolid |  | 2015-12-21 |  |  |
| Allergan | Avibactam, Ceftazidime | Avycaz | 2026-01-07 | 2015-02-25 | $98.8 M | Q2/19-Q1/20 |
| Levofloxacin | Levofloxacin |  | 2011-02-10 |  |  | |
| Amneal Pharmaceuticals | Linezolid | Linezolid |  | 2015-12-21 |  |  |
| Tigecycline | Tigecycline | 2033-04-07 | 2018-08-02 |  |  | |
| ANDA Repository | Ceftriaxone | Ceftriaxone |  | 2017-01-20 |  |  |
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
70%16/23
Phase 3
64%50/78
Approved: 38Overall Success rate: 45%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use